314 related articles for article (PubMed ID: 21128826)
21. [In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
Rubio Calvo MC; Gil J; Ramírez de Ocáriz I; Benito R; Rezusta A
Rev Esp Quimioter; 2003 Jun; 16(2):227-32. PubMed ID: 12973462
[TBL] [Abstract][Full Text] [Related]
22. Antifungal activity and influence of propolis against germ tube formation as a critical virulence attribute by clinical isolates of Candida albicans.
Haghdoost NS; Salehi TZ; Khosravi A; Sharifzadeh A
J Mycol Med; 2016 Dec; 26(4):298-305. PubMed ID: 27789229
[TBL] [Abstract][Full Text] [Related]
23. A survey of the in vitro antifungal activity of heather (Erica sp.) organic honey.
Feás X; Estevinho ML
J Med Food; 2011 Oct; 14(10):1284-8. PubMed ID: 21663476
[TBL] [Abstract][Full Text] [Related]
24. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Panizo MM; Reviákina V; Dolande M; Selgrad S
Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
[TBL] [Abstract][Full Text] [Related]
25. Antifungal activity of propolis extract against yeasts isolated from onychomycosis lesions.
Oliveira AC; Shinobu CS; Longhini R; Franco SL; Svidzinski TI
Mem Inst Oswaldo Cruz; 2006 Aug; 101(5):493-7. PubMed ID: 17072451
[TBL] [Abstract][Full Text] [Related]
26. Honey, Propolis, and Royal Jelly: A Comprehensive Review of Their Biological Actions and Health Benefits.
Pasupuleti VR; Sammugam L; Ramesh N; Gan SH
Oxid Med Cell Longev; 2017; 2017():1259510. PubMed ID: 28814983
[TBL] [Abstract][Full Text] [Related]
27. [Antifungal activity of melanin in clinical isolates of Candida spp].
Fuentes M; Hernández R; Gordillo D; Amaro J; Falconer MA; Alburquenque C; Tapia CV
Rev Chilena Infectol; 2014 Feb; 31(1):28-33. PubMed ID: 24740771
[TBL] [Abstract][Full Text] [Related]
28. In vitro antifungal activity of phenylheptatriyne from Bidens cernua L. against yeasts.
Rybalchenko NP; Prykhodko VA; Nagorna SS; Volynets NN; Ostapchuk AN; Klochko VV; Rybalchenko TV; Avdeeva LV
Fitoterapia; 2010 Jul; 81(5):336-8. PubMed ID: 19837144
[TBL] [Abstract][Full Text] [Related]
29. [The in vitro antifungal activities of fluconazole against pathogenic yeasts recently isolated from clinical specimens].
Yamaguchi H; Igari J; Kume H; Abe M; Oguri T; Kanno H; Kawakami S; Okuzumi K; Fukayama M; Ito A; Kawata K; Uchida K
Jpn J Antibiot; 1997 Sep; 50(9):799-805. PubMed ID: 9394240
[TBL] [Abstract][Full Text] [Related]
30. [CHROMAgar Candida with fluconazole: comparison with microdilution techniques].
Linares MJ; Charriel G; Solís F; Casal M
Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):493-7. PubMed ID: 14572382
[TBL] [Abstract][Full Text] [Related]
31. Role of yeasts as nosocomial pathogens & their susceptibility to fluconazole & amphotericin B.
Prasad KN; Agarwal J; Dixit AK; Tiwari DP; Dhole TN; Ayyagari A
Indian J Med Res; 1999 Jul; 110():11-7. PubMed ID: 10709333
[TBL] [Abstract][Full Text] [Related]
32. In vitro evaluation of the acquisition of resistance, antifungal activity and synergism of Brazilian red propolis with antifungal drugs on Candida spp.
Pippi B; Lana AJ; Moraes RC; Güez CM; Machado M; de Oliveira LF; Lino von Poser G; Fuentefria AM
J Appl Microbiol; 2015 Apr; 118(4):839-50. PubMed ID: 25565139
[TBL] [Abstract][Full Text] [Related]
33. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002.
Yang YL; Li SY; Cheng HH; Lo HJ;
Diagn Microbiol Infect Dis; 2005 Mar; 51(3):179-83. PubMed ID: 15766603
[TBL] [Abstract][Full Text] [Related]
34. [In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints].
Calışkan S; Keçeli Özcan S; Cınar S; Corakçı A; Calışkan E
Mikrobiyol Bul; 2011 Oct; 45(4):697-706. PubMed ID: 22090300
[TBL] [Abstract][Full Text] [Related]
35. Synergistic effects of honey and propolis toward drug multi-resistant Staphylococcus aureus, Escherichia coli and Candida albicans isolates in single and polymicrobial cultures.
Al-Waili N; Al-Ghamdi A; Ansari MJ; Al-Attal Y; Salom K
Int J Med Sci; 2012; 9(9):793-800. PubMed ID: 23136543
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the VITEK 2 system to test the susceptibility of Candida spp., Trichosporon asahii and Cryptococcus neoformans to amphotericin B, flucytosine, fluconazole and voriconazole: a comparison with the M27-A3 reference method.
Cejudo MA; Gallego AG; Lacasa EC; Aller AI; Romero A; García JP; Andrés GQ; Martín-Mazuelos E
Med Mycol; 2010 Aug; 48(5):710-9. PubMed ID: 20109092
[TBL] [Abstract][Full Text] [Related]
37. [In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].
Blanco MT; Cañadas J; García-Martos P; Marín P; García-Tapia A; Rodríguez J
Rev Esp Quimioter; 2009 Sep; 22(3):139-43. PubMed ID: 19662547
[TBL] [Abstract][Full Text] [Related]
38. [In vitro pharmacological study of fluconazole. Evaluation of an antifungal assay].
Duval F; Lavarde V
Pathol Biol (Paris); 1993 May; 41(5):469-73. PubMed ID: 8414680
[TBL] [Abstract][Full Text] [Related]
39. Antifungal susceptibility and distribution of Candida spp. isolates from the University Hospital in the municipality of Dourados, State of Mato Grosso do Sul, Brazil.
Almeida AA; Mesquita CS; Svidzinski TI; Oliveira KM
Rev Soc Bras Med Trop; 2013; 46(3):335-9. PubMed ID: 23856873
[TBL] [Abstract][Full Text] [Related]
40. Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.
Ozhak-Baysan B; Ogunc D; Colak D; Ongut G; Donmez L; Vural T; Gunseren F
Med Mycol; 2012 Jul; 50(5):529-32. PubMed ID: 21988703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
